NCT00392015View on ClinicalTrials.gov

NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

October 12, 2006

Primary Completion Date

June 2, 2016

Study Completion Date

September 25, 2017

Conditions
Plasmodium Falciparum
Interventions
BIOLOGICAL

NMRC-M3V-Ad-PfCA

Malaria Vaccine

BIOLOGICAL

NMRC-MV-Ad-PfC, NMRC-M3V-Ad-PfCA

Malaria Vaccines

Trial Locations (1)

20889-5607

Naval Medical Research Center (NMRC) Clinical Trials Center, Bethesda

Sponsors
All Listed Sponsors
collaborator

United States Agency for International Development (USAID)

FED

collaborator

Congressionally Directed Medical Research Programs

FED

collaborator

Military Infectious Diseases Research Program (MIDRP)

NETWORK

collaborator

Naval Medical Research Center

FED

lead

U.S. Army Medical Research and Development Command

FED

NCT00392015 - NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1 | Biotech Hunter | Biotech Hunter